SG11201504641SA - Eicosapentaenoic acid (epa) formulations - Google Patents

Eicosapentaenoic acid (epa) formulations

Info

Publication number: SG11201504641SA
Authority: SG; Singapore
Prior art keywords: epa; formulations; eicosapentaenoic acid; eicosapentaenoic; acid
Prior art date: 2012-12-24

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-12Priority claimed from US13/797,802external-prioritypatent/US9629820B2/en

2013-12-18Application filed by Qualitas Health LtdfiledCriticalQualitas Health Ltd

2015-07-30Publication of SG11201504641SApublicationCriticalpatent/SG11201504641SA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
- C11B1/104—Production of fats or fatty oils from raw materials by extracting using super critical gases or vapours
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B3/00—Refining fats or fatty oils
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B7/00—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B7/00—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
- C11B7/0008—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents
- C11B7/0025—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents in solvents containing oxygen in their molecule
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B7/00—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils
- C11B7/0008—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents
- C11B7/005—Separation of mixtures of fats or fatty oils into their constituents, e.g. saturated oils from unsaturated oils by differences of solubilities, e.g. by extraction, by separation from a solution by means of anti-solvents in solvents used at superatmospheric pressures
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Wood Science & Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Natural Medicines & Medicinal Plants (AREA)
Hematology (AREA)
Biotechnology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Microbiology (AREA)
Analytical Chemistry (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Endocrinology (AREA)
Obesity (AREA)

SG11201504641SA2012-12-242013-12-18Eicosapentaenoic acid (epa) formulationsSG11201504641SA (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201261745740P	2012-12-24	2012-12-24
US13/797,802US9629820B2 (en)	2012-12-24	2013-03-12	Eicosapentaenoic acid (EPA) formulations
US201361816561P	2013-04-26	2013-04-26
PCT/US2013/076178WO2014105576A1 (en)	2012-12-24	2013-12-18	Eicosapentaenoic acid (epa) formulations

Publications (1)

Publication Number	Publication Date
SG11201504641SAtrue SG11201504641SA (en)	2015-07-30

Family

ID=51021961

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG11201504641SASG11201504641SA (en)	2012-12-24	2013-12-18	Eicosapentaenoic acid (epa) formulations
SG10201709538QASG10201709538QA (en)	2012-12-24	2013-12-18	Eicosapentaenoic acid (epa) formulations

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG10201709538QASG10201709538QA (en)	2012-12-24	2013-12-18	Eicosapentaenoic acid (epa) formulations

Country Status (12)

Country	Link
EP (1)	EP2934505B1 (en)
JP (1)	JP6538564B2 (en)
KR (1)	KR102271711B1 (en)
AU (1)	AU2013371074B2 (en)
CA (1)	CA2894709C (en)
ES (1)	ES2875975T3 (en)
MX (1)	MX372724B (en)
NZ (1)	NZ709083A (en)
PT (1)	PT2934505T (en)
SG (2)	SG11201504641SA (en)
WO (1)	WO2014105576A1 (en)
ZA (1)	ZA201504480B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20120172445A1 (en)	2010-12-29	2012-07-05	Abbott Laboratories	Nutritional products including a novel fat system including fatty acids
US10123986B2 (en)	2012-12-24	2018-11-13	Qualitas Health, Ltd.	Eicosapentaenoic acid (EPA) formulations
US9629820B2 (en)	2012-12-24	2017-04-25	Qualitas Health, Ltd.	Eicosapentaenoic acid (EPA) formulations
EP2983516A1 (en)	2013-03-13	2016-02-17	Abbott Laboratories	A composition for enhancing newborn infant cognitive, brain and/or cns development and method of using same
BR112015022995A2 (en)	2013-03-13	2017-07-18	Abbott Lab	infant nutritional product with rrr-alpha tocopherol
CN107847477A (en)	2015-05-13	2018-03-27	Ds生物制药有限公司	Compositions comprising 15-oxo-EPA or 15-oxo-DGLA and methods for their preparation and use
JP2018168139A (en)*	2016-10-21	2018-11-01	マルハニチロ株式会社	Composition for reducing or increasing neutral fat value containing n-3 unsaturated fatty acid, and use of n-3 unsaturated fatty acid in the production of the composition
WO2018204670A1 (en)*	2017-05-04	2018-11-08	The Board Of Trustees Of The Leland Stanford Junior University	Neurodevelopment-promoting food compositions and kits, systems and methods related thereto
IL275534B2 (en)	2017-12-21	2024-09-01	Aker Biomarine Antarctic As	Lysophosphatidylcholine compounds
PL242879B1 (en)*	2018-01-08	2023-05-08	Skotan Spolka Akcyjna	Oral compositions containing the Yarrowia lipolytica yeast biomass, preferably enriched with zinc, selenium and chromium
KR102116046B1 (en)*	2018-03-22	2020-05-27	뉴트리진 주식회사	A composition for preventing or treating cognitive impairment comprising an omega3 fatty acid
KR102086830B1 (en)*	2018-03-27	2020-03-09	한국해양과학기술원	Liquid fatty composition containing polyunsaturated fatty acids derived from algae and method of manufacturing
EP3781190A1 (en)	2018-04-20	2021-02-24	Nano Algae Solutions AG	A novel process for providing eicosapentaenoic oil compositions
EP3586642A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Ala enriched polyunsaturated fatty acid compositions
EP3586643A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
EP3586640A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
EP3586641A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
CN112512542B (en)*	2018-07-31	2024-03-19	株式会社电装	Anti-norovirus agent
US20220409551A1 (en)*	2019-06-18	2022-12-29	Vaxa Technologies Ltd.	Composition comprising polar lipids and method of making same
US11638731B2 (en)	2019-11-20	2023-05-02	Nooter/Eriksen, Inc.	Medical compositions with Omega-3 containing excipients
IL293602A (en)*	2019-12-05	2022-08-01	Vaxa Tech Ltd	Nutritional supplement for animals and aquaculture and a method for its preparation
US20210315851A1 (en)	2020-04-03	2021-10-14	Afimmune Limited	Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
US11730782B2 (en)	2020-11-20	2023-08-22	Nooter/Eriksen, Inc	Processes for producing omega-3 containing compositions from algae and related extractions
US11298387B1 (en)	2020-11-20	2022-04-12	Nooter/Eriksen, Inc.	Omega-3 containing compositions
CN116723827A (en)*	2020-11-20	2023-09-08	努特埃里克森公司	Improved omega-3 containing compositions
CN115215725A (en)*	2021-04-15	2022-10-21	宋晓瑜	Method for preparing lavender acetate and lavender alcohol
IL316329A (en)*	2022-04-11	2024-12-01	Nooter/Eriksen Inc	Improved processes for producing omega-3 containing compositions from algae and related extractions
IT202200014677A1 (en)*	2022-07-13	2024-01-13	Eni Spa	PROCESS FOR THE PRODUCTION OF POLYUNSATURATED FATTY ACIDS IN THE FORM OF ESTERS
WO2025114645A1 (en)*	2023-11-30	2025-06-05	Neste Oyj	A process and system for separating algal hydrophobic products from an algal biomass stream

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2729586A (en)*	1952-02-01	1956-01-03	Rystan Company	Therapeutic compositions comprising water - soluble chlorophyll and salts of fatty acids
JPS6164794A (en)*	1984-09-05	1986-04-03	日清製油株式会社	Fish odor free epa-containing lipid component
JPS62239981A (en)*	1986-04-11	1987-10-20	Kurorera Kogyo Kk	Production of algal body with high eicosapentaenoic acid content
DE3783396T2 (en)	1986-07-08	1993-07-29	Suntory Ltd	METHOD FOR PRODUCING BISHOMO GAMMA LINOLIC ACID AND EICOSAPENTIC ACID.
US5246841A (en)	1986-12-26	1993-09-21	Sagami Chemical Research Center	Microbial process for production of eicosapentaenoic acid
US5244921A (en)	1990-03-21	1993-09-14	Martek Corporation	Eicosapentaenoic acids and methods for their production
US5246842A (en)	1991-10-30	1993-09-21	The United States Of America As Represented By The Secretary Of Agriculture	Production of eicosapentaenoic acid from filamentous fungi utilizing lactose as a primary carbon source
JPH09252761A (en)*	1996-03-22	1997-09-30	Yoshio Tanaka	Culture of nannochloropsis algae increasing production of eicosapentaenoic acid
JPH10276724A (en)*	1997-04-02	1998-10-20	Q P Corp	Poultry eggs containing high concentrations of arachidonic acid
DK1272049T3 (en)*	2000-04-12	2010-03-22	Gea Westfalia Separator Gmbh	Process for fractionation of oil and polar lipid-containing native raw materials using alcohol and centrifugation
AU2002309856B2 (en)*	2001-05-14	2008-10-23	Dsm Ip Assets B.V.	Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
US7238482B2 (en)	2003-05-07	2007-07-03	E. I. Du Pont De Nemours And Company	Production of polyunsaturated fatty acids in oleaginous yeasts
US7935365B2 (en)*	2003-10-22	2011-05-03	Enzymotec, Ltd.	Glycerophospholipids for the improvement of cognitive functions
CA2549429A1 (en)*	2003-12-22	2005-07-07	Wakunaga Pharmaceutical Co., Ltd.	Fat composition
JP2005206789A (en)*	2003-12-22	2005-08-04	Wakunaga Pharmaceut Co Ltd	New oil and fat composition
ATE479757T1 (en)	2004-06-04	2010-09-15	Fluxome Sciences As	CELLS MANUFACTURED BY METABOLIC TECHNOLOGY FOR THE PRODUCTION OF POLYUNSATURATED FATTY ACIDS
US7550286B2 (en)	2004-11-04	2009-06-23	E. I. Du Pont De Nemours And Company	Docosahexaenoic acid producing strains of Yarrowia lipolytica
AU2006242914B2 (en)*	2005-05-04	2012-02-02	Pronova Biopharma Norge As	New DHA derivatives and their use as medicaments
US20080044487A1 (en)*	2006-05-05	2008-02-21	Natural Asa	Anti-inflammatory properties of marine lipid compositions
NZ547429A (en)*	2006-05-24	2009-09-25	Ind Res Ltd	Extraction of highly unsaturated lipids with liquid dimethyl ether
US8877465B2 (en)*	2006-07-05	2014-11-04	Photonz Corporation Limited	Production of ultrapure EPA and polar lipids from largely heterotrophic culture
JP5711968B2 (en)	2007-10-03	2015-05-07	イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．ＤｕＰｏｎｔＤｅＮｅｍｏｕｒｓＡｎｄＣｏｍｐａｎｙ	An optimized strain of Yarrowia Lipolytica to produce high eicosapentaenoic acid
EP2156744A1 (en)*	2008-08-11	2010-02-24	Nestec S.A.	Oil containing one or more long-chain polyunsaturated fatty acids phospholipids derived from biomass
EP3578177A1 (en)*	2008-09-02	2019-12-11	Amarin Pharmaceuticals Ireland Limited	Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
US8735140B2 (en)	2008-11-07	2014-05-27	Kuehnle Agrosystems, Inc.	Preservation and composition of bioprocess algae for production of lipids, seedstock, and feed
EP4008327A1 (en)*	2009-04-29	2022-06-08	Amarin Pharmaceuticals Ireland Limited	Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
US8637298B2 (en)	2009-06-16	2014-01-28	E I Du Pont De Nemours And Company	Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production
US20110081706A1 (en)	2009-10-02	2011-04-07	TransAlgae Ltd	Method and system for efficient harvesting of microalgae and cyanobacteria
PH12012501984A1 (en)	2010-04-06	2013-01-14	Heliae Dev Llc	Methods of and systems for dewatering algae and recycling water therefrom
CA2825037A1 (en)*	2011-02-11	2012-08-16	E.I. Du Pont De Nemours And Company	An eicosapentaenoic acid concentrate
JP6061866B2 (en)	2011-02-11	2017-01-18	イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．ＤｕＰｏｎｔＤｅＮｅｍｏｕｒｓＡｎｄＣｏｍｐａｎｙ	Method for obtaining a lipid-containing composition from microbial biomass
US20140051877A1 (en)	2011-04-28	2014-02-20	Nandakishore Jeevanrao Duragkar	Eicosapentaenoic acid (epa) as polyunsaturated free fatty acid in its directly compressible powder form and process of isolation thereof
US10160989B2 (en)	2011-05-02	2018-12-25	Renewuel Llc	System and method of co-cultivating microalgae with fungus

2013
- 2013-12-18SGSG11201504641SApatent/SG11201504641SA/enunknown
- 2013-12-18PTPT138674338Tpatent/PT2934505T/enunknown
- 2013-12-18SGSG10201709538QApatent/SG10201709538QA/enunknown
- 2013-12-18WOPCT/US2013/076178patent/WO2014105576A1/enactiveApplication Filing
- 2013-12-18MXMX2015008199Apatent/MX372724B/enactiveIP Right Grant
- 2013-12-18CACA2894709Apatent/CA2894709C/enactiveActive
- 2013-12-18ESES13867433Tpatent/ES2875975T3/enactiveActive
- 2013-12-18AUAU2013371074Apatent/AU2013371074B2/enactiveActive
- 2013-12-18KRKR1020157020271Apatent/KR102271711B1/enactiveActive
- 2013-12-18NZNZ709083Apatent/NZ709083A/enunknown
- 2013-12-18JPJP2015549635Apatent/JP6538564B2/enactiveActive
- 2013-12-18EPEP13867433.8Apatent/EP2934505B1/enactiveActive
2015
- 2015-06-22ZAZA2015/04480Apatent/ZA201504480B/enunknown

Also Published As

Publication number	Publication date
CA2894709C (en)	2022-08-09
EP2934505B1 (en)	2021-05-19
EP2934505A1 (en)	2015-10-28
SG10201709538QA (en)	2017-12-28
JP6538564B2 (en)	2019-07-03
KR102271711B1 (en)	2021-07-01
EP2934505A4 (en)	2016-11-30
PT2934505T (en)	2021-07-02
NZ749326A (en)	2020-10-30
ES2875975T3 (en)	2021-11-11
ZA201504480B (en)	2017-11-29
MX372724B (en)	2020-06-19
KR20150110555A (en)	2015-10-02
WO2014105576A1 (en)	2014-07-03
CA2894709A1 (en)	2014-07-03
AU2013371074B2 (en)	2018-07-26
AU2013371074A1 (en)	2015-07-02
NZ709083A (en)	2020-07-31
JP2016504999A (en)	2016-02-18
MX2015008199A (en)	2015-12-01

Publication	Publication Date	Title
ZA201504480B (en)	2017-11-29	Eicosapentaenoic acid (epa) formulations
TWI563077B (en)	2016-12-21	Cleaning formulations
ZA201501847B (en)	2016-01-27	Formulations of enzalutamide
ZA201500212B (en)	2017-04-26	Progesterone formulations
ZA201308606B (en)	2015-05-27	Nutritional compositions having alpha-hica and eicosapentaenoic acid
IL236304A0 (en)	2015-02-26	Diclofenac formulations
ZA201407373B (en)	2016-10-26	Novel pharmaceutical formulations
AP4063A (en)	2017-03-09	Dimethyl-benzoic acid compounds
IL237804A0 (en)	2015-05-31	Apixaban liquid formulations
EP2908636A4 (en)	2017-05-31	Compositions comprising peroxy acid
EP2825057B8 (en)	2020-06-24	Oxidixable fatty acid composition delivery form
PL2753311T3 (en)	2020-12-14	Antioxidant formulations
GB201110278D0 (en)	2011-08-03	Formulations
GB201221125D0 (en)	2013-01-09	Pharmaceutial formulations
PL2900088T3 (en)	2017-06-30	Liquid concentrated vitamin e compositions
IL227905A0 (en)	2013-09-30	Toroidal pharmaceutical formulations
GB201206178D0 (en)	2012-05-23	Formulations
GB201111578D0 (en)	2011-08-24	Pharmeutical formulations
GB201111013D0 (en)	2011-08-10	Formulations
GB201107626D0 (en)	2011-06-22	Formulations
GB201107627D0 (en)	2011-06-22	Formulations
GB201105410D0 (en)	2011-05-11	Formulations
GB201105360D0 (en)	2011-05-11	Formulations
GB201104049D0 (en)	2011-04-20	Formulations
GB201104048D0 (en)	2011-04-20	Formulations

Movatterモバイル変換

SG11201504641SA - Eicosapentaenoic acid (epa) formulations - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (4)

Publications (1)

Family

ID=51021961

Family Applications (2)

Family Applications After (1)

Country Status (12)

Families Citing this family (29)

Family Cites Families (33)

Also Published As

Similar Documents